Detailed answers about MS PHARMA CONSULTING LIMITED, including incorporation, status, business activity, and accounts information.
When was MS PHARMA CONSULTING LIMITED founded?
MS PHARMA CONSULTING LIMITED was officially incorporated on 5 June 2024 and is registered under company number 15761600. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is MS PHARMA CONSULTING LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of MS PHARMA CONSULTING LIMITED?
MS PHARMA CONSULTING LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does MS PHARMA CONSULTING LIMITED do?
MS PHARMA CONSULTING LIMITED operates in the following sectors: 46460 - Wholesale of pharmaceutical goods, 64203 - Activities of construction holding companies, 70229 - Management consultancy activities other than financial management, 72200 - Research and experimental development on social sciences and humanities. These SIC codes provide insight into the company's business activities and industry focus.
What is MS PHARMA CONSULTING LIMITED's registered address?
The registered office address of MS PHARMA CONSULTING LIMITED is FLAT 8 PEAR TREE HOUSE, BROCKLEY ROAD, LONDON, ENGLAND, SE4 2RY. This is the official address filed with Companies House for legal and statutory correspondence.
Is MS PHARMA CONSULTING LIMITED financially stable?
Financial accounts for MS PHARMA CONSULTING LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.